Annandale Capital »

Ocuphire Pharma shares owned by Annandale Capital

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Annandale Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $165 10k 0.02

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Global X Fds Glb X Mlp Enrg I (MLPX)
Uber Technologies (UBER)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Annandale Capital

Top funds holding Ocuphire Pharma

Perceptive Advisors
BIOS Capital Management
Nantahala Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Voss Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Creative Planning
Citadel Advisors
Two Sigma Investments

View all funds holding Ocuphire Pharma